It was recently reported that the H3.3 G34 oncohistones associated with giant cell tumor of bone and pediatric gliomas selectively promote PRC2 activity by blocking SETD2-mediated H3K36 methylation [43, 44]. This evidence concerns the gene SETD2 and central nervous system cancer.